Postoperative hypocalcemia is the most common complication after total thyroidectomy. For years, two camps have debated the best prevention strategy: supplement everyone routinely, or check a postoperative PTH and supplement selectively. Despite this being a fundamental clinical question, no randomized trial had ever compared them head-to-head. Until now.

Garcia-Lozano et al. published the first diagnostic RCT on this question in JAMA Otolaryngology this week, randomizing 258 patients across three centers in Colombia to either routine calcium/calcitriol for 15 days or PTH-guided selective supplementation (supplement only if 4-hour PTH <15 pg/mL).

The Two Arms

Results

Neither difference was statistically significant (P = .36 and P = .53, respectively).

A note on the paper: The abstract reports these symptomatic hypocalcemia rates in reverse (PTH 7.8%, C+C 11.1%), but mathematical verification confirms the OR of 0.68 is only consistent with the Table 2 assignment shown above.

The Practical Finding

The PTH-guided approach reduced supplementation use by 57–65%. Only 43% of patients in the selective group needed calcium and calcitriol, compared with 100% in the routine group. That spares most patients 15 days of supplementation they did not need.

Bottom Line: Both strategies work. If you have a reliable, rapid PTH assay, the selective approach reduces overtreatment with no significant increase in hypocalcemia. If PTH turnaround is slow, costly, or unavailable, routine prophylaxis works just as well. Your choice depends on local resources, workflow, and surgeon preference.

🎙️ Full episode analysis and podcast: Episode 011 – RCT: Routine vs PTH-Guided Calcium Supplementation After Total Thyroidectomy

Head and Neck Oncology Journal Club

Krishnakumar Thankappan

Join the Club. New episodes every week covering the latest in head and neck oncology research.

Know a colleague who'd find this useful? Forward this email or share the link. Questions, comments, or paper suggestions? Just reply to this email.